Opendata, web and dolomites

HYscreen

A fast, cost-effective breath analysis technology for Helicobacter pYlori screening at both large and small scale.

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 HYscreen project word cloud

Explore the words cloud of the HYscreen project. It provides you a very rough idea of what is the project "HYscreen" about.

unnecessary    feasibility    secondary    offers    expertise    simplicity    commercially    diagnosis    global    screening    oxide    affordable    consequently    doors    too    ulcers    oxidizer    gastric    bill    ltd    population    healthcare    diagnostics    infection    tests    clinical    scientific    rapid    air    lower    decisions    programs    reduce    biomarker    fast    care    solutions    sensor    trials    link    optimization    duodenal    expensive    though    usa    prototype    monitoring    asia    urea    absorption    validation    inconvenient    cancer    bedfont    plan    time    breath    device    protection    helicobacter    business    close    costly    realized    simpler    ulceration    mouthpiece    lymphoma    primary    shorten    thermal    optimizing    portable    give    66    final    preventing    savings    impetus    incidence    avoiding    hyscreen    endoscopies    c12    pylori    nitrogen    cheaper    innovation    treatment    respectively    aesthetics    infections    solution    diagnostic    detects    ultimately    sampling    exhaled    convenience    market    invasive    entrapment    accuracy    biopsies    ammonia    quicker    answering    billion   

Project "HYscreen" data sheet

The following table provides information about the project.

Coordinator
Bedfont Scientific Limited 

Organization address
address: Station Yard, Station Road
city: Maidstone
postcode: ME17 1JA
website: n.a.

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country United Kingdom [UK]
 Project website https://www.bedfont.com
 Total cost 71˙429 €
 EC max contribution 50˙000 € (70%)
 Programme 1. H2020-EU.3.1.3. (Treating and managing disease)
 Code Call H2020-SMEINST-1-2014
 Funding Scheme SME-1
 Starting year 2015
 Duration (year-month-day) from 2015-05-01   to  2015-10-31

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    Bedfont Scientific Limited UK (Maidstone) coordinator 50˙000.00

Map

 Project objective

The increasing incidence of Helicobacter (H.) pylori infections and their close link with gastric cancer, gastric lymphoma, duodenal and gastric ulceration, give impetus to the H. pylori diagnostics market. Existing solutions are too costly, inconvenient and invasive; have a long analysis time or need technical expertise to analyse. Bedfont Scientific Ltd offers a portable H. pylori diagnostic device, HYscreen, which detects ammonia in exhaled air as a biomarker for H. pylori. It has a rapid diagnosis, higher accuracy, lower cost, greater simplicity and convenience. It has the following innovation features: a mouthpiece breath entrapment sampling system, a thermal oxidizer and a Nitrogen Oxide (NO) sensor. This solution is aimed at primary and secondary care in Europe and USA and population screening programs in Asia, answering the call for a cheaper, quicker and simpler monitoring device. This will lead to improved clinical decisions that will facilitate early treatment of the infection, preventing H pylori related cases of gastric cancer and gastric or duodenal ulcers. Consequently, Europe-wide and global savings of up to €1.5 billion and €5.66 billion respectively will be realized by avoiding unnecessary endoscopies, biopsies, expensive H. pylori tests and the healthcare bill from H. pylori-related conditions. Ultimately, HYscreen will open doors for fast and affordable population wide screening. The test will use cheaper C12 urea, though work still needs to be done to make it commercially available. There is a challenge to shorten the thermal oxidizer system for better aesthetics and to reduce ammonia absorption. In Phase 1, we study the feasibility of optimizing the thermal oxidizer system, the use and optimization of C12 urea, protection of the product and the detailed business plan. Phase 2 will produce the final product from the prototype along with the validation steps and clinical trials.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "HYSCREEN" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "HYSCREEN" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.3.1.3.)

PanCareFollowUp (2019)

PanCareFollowUp: Novel, patient-centred survivorship care to improve care quality, effectiveness, cost-effectiveness and accessibility for survivors and caregivers

Read More  

GACD (2019)

Global Alliance for Chronic Diseases Secretariat

Read More  

LEGACy (2019)

CeLac and European consortium for a personalized medicine approach to Gastric Cancer

Read More